ONCOCROSS
- Biotech or pharma, therapeutic R&D
AI platform-based biotech innovating drug development process
Our AI platform RAPTOR AI™ powers indication identification and expansion by unlocking optimal drug-disease matches through transcriptome-driven insights.
• AI-Driven Indication Discovery & Expansion
RAPTOR AI™ identifies the most promising clinical indications and supports novel indication expansion
— not only accelerating development but also reviving previously failed or shelved assets through transcriptome-based insights.
• Proven Global Partnerships
We’ve successfully partnered with leading pharma companies, with several collaborations extended into follow-on agreements — a testament to the trust and value we deliver.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}